400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2021-12-15
抗体药物偶联物 (ADC)开发商
医药研发/制造
化学&生物药
Refactor Capital;
Refactor Capital;
LifeForce Capital;
LifeForce Capital;
First Round Capital;
Perceptive Advisors;
Highside Capital Management;
Venrock Capital;
OMX Ventures;
Viking Global Investors;
Foresite Capital
2021-08-02
基于人工智能的质谱平台研发商
医疗器械
医疗信息化
True Ventures;
True Ventures;
Heritage Provider Network;
Heritage Provider Network;
Anzu Partners;
Genoa Ventures;
Irving Investors;
Highside Capital Management;
Amplify Partners
2021-07-28
精准肿瘤学研究商
医药研发/制造
化学&生物药
辉瑞;
辉瑞;
Baird Capital;
Baird Capital;
Arboretum Ventures;
Deerfield;
鱼鹰资管;
Highside Capital Management;
Wellington Management;
Renaissance Venture Capital Fund;
Monashee Investment Management;
Merck GHI Fund
2020-06-04
神经退行性疾病治疗用新药研发商
医药研发/制造
化学&生物药
Logos Capital;
Logos Capital;
Franklin Templeton Investments;
Franklin Templeton Investments;
Perceptive Advisors;
RTW Investments;
Sofinnova Partners;
LifeSci Venture Partners;
Suzanne Kayne;
Highside Capital Management;
Avidity Partners;
Janus Henderson Investors;
Viking Global Investors;
Sahsen Ventures;
Rick;
Rock Springs Capital;
Surveyor Capital;
Venrock Capital
中国农药工业协会2026-01-26
经纬创投2026-01-26
GMP办公室2026-01-26
功能与专用化学品2026-01-26
一度医药2026-01-26
细胞与基因治疗领域2026-01-26
同写意2026-01-26
CIO合规保证组织2026-01-26
德联资本2026-01-26
生物安全情报网2026-01-26